Tizanidine hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71209-064 -
Package NDC
71209-064-07 -
Application number
ANDA210021 -
SPL ID
6edcd49b-7ddf-4ca2-9946-6f1ff6bf22e1 -
SPL set ID
f2f4e117-0318-4bbd-aaa7-fab803714f21 -
UNII
B53E3NMY5C -
RxCUI
485484 -
RxCUI
485485 -
RxCUI
485486
What the source publishes
- Labeler
- Cadila Pharmaceuticals Limited
- Active ingredients
- Tizanidine hydrochloride
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Tizanidine hydrochloride",
"splId": "6edcd49b-7ddf-4ca2-9946-6f1ff6bf22e1",
"labels": [
{
"setId": "f2f4e117-0318-4bbd-aaa7-fab803714f21",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2f4e117-0318-4bbd-aaa7-fab803714f21",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f2f4e117-0318-4bbd-aaa7-fab803714f21"
}
],
"routes": [
"ORAL"
],
"labeler": "Cadila Pharmaceuticals Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "150 CAPSULE in 1 BOTTLE (71209-064-07)",
"package_ndc": "71209-064-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20171229"
}
],
"productId": "71209-064_6edcd49b-7ddf-4ca2-9946-6f1ff6bf22e1",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "71209-064",
"deaSchedule": null,
"genericName": "Tizanidine hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TIZANIDINE HYDROCHLORIDE",
"strength": "2 mg/1"
}
],
"applicationNumber": "ANDA210021",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20171229",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0371209064071",
"0371209065078",
"0371209066075"
],
"unii": [
"B53E3NMY5C"
],
"rxcui": [
"485484",
"485485",
"485486"
],
"spl_set_id": [
"f2f4e117-0318-4bbd-aaa7-fab803714f21"
],
"manufacturer_name": [
"Cadila Pharmaceuticals Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71209-064_6edcd49b-7ddf-4ca2-9946-6f1ff6bf22e1"